Panjiva Daily: 27 billion threats to phase 1; Roche rescues falling test kit shipments

Global 1074 Panjiva Daily 480

China’s imports of products covered by the phase 1 trade deal improved versus a year earlier in April, but year-to-date are still $27 billion behind schedule. U.S. medical supply shipments surged in April except for test kits though data for May suggests a turnaround is underway. Also: retail needs new services after Hapag-Lloyd, ONE draw more blanks; USMCA’s benefits sorely needed as U.S. trade slump on COVID-19 closures; Panjiva Insights: The state of global trade in light of COVID-19 and the trade war; Chinese bean buying continues at a low rate, but Lighthizer’s happy; USMCA’s unifor...

Copyright © 2020 Panjiva Supply Chain Intelligence, a product offering from S&P Global Market Intelligence Inc. All rights reserved.